The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Rating of “Hold” by Analysts

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned an average recommendation of “Hold” from the sixteen research firms that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $81.3077.

Several equities analysts have issued reports on COO shares. Citigroup reaffirmed a “neutral” rating and set a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday. Weiss Ratings downgraded Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. Stifel Nicolaus decreased their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Finally, Wells Fargo & Company restated a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th.

Cooper Companies Stock Performance

Shares of COO stock opened at $65.42 on Thursday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $12.76 billion, a P/E ratio of 55.44, a P/E/G ratio of 1.72 and a beta of 0.88. Cooper Companies has a 12-month low of $58.89 and a 12-month high of $89.83. The business’s 50 day moving average is $64.27 and its two-hundred day moving average is $73.86.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts expect that Cooper Companies will post 4.63 EPS for the current fiscal year.

Hedge Funds Weigh In On Cooper Companies

Several institutional investors and hedge funds have recently bought and sold shares of COO. New York Life Investment Management LLC grew its holdings in shares of Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after purchasing an additional 158 shares during the period. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the last quarter. Essential Partners LLC raised its stake in shares of Cooper Companies by 23.4% in the 1st quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after acquiring an additional 166 shares during the period. Allworth Financial LP raised its stake in shares of Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares during the period. Finally, Mesirow Financial Investment Management Inc. raised its stake in shares of Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after acquiring an additional 175 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.